WILMINGTON, Delaware, Oct. 6 -- AstraZeneca, a biopharmaceutical company, issued the following news release:

* * *

AstraZeneca opens new global strategic R&D center in Kendall Square, Cambridge, Massachusetts

5 October 2026

$1 billion investment will grow AstraZeneca's workforce in Massachusetts by over 50% and deliver next-generation medicines

-

AstraZeneca today announced the opening of its newest global str . . .

Click here for more information about our products